Clinical trial

Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis

NCT01990157

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-11-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2013-11-01Date precision: month

Registry last updated2017-02-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

TAB08DRUG

Sponsors & collaborators

Theramab LLClead sponsor

Mapped research locations

MoscowRussia1 YaroslavlRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01990157 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.